Cellectis Logo.png
Monthly information on share capital and company voting rights
May 10, 2021 16:30 ET | Cellectis Inc.
NEW YORK, May 10, 2021 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number of sharesin the capitalTotal number of voting...
Neovasc_Logo-web-header.jpg
Neovasc Announces First Patient Enrollment in COSIMA Trial
May 10, 2021 09:05 ET | Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, May 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the first patient has been enrolled...
Onconova Logo BLUE.jpg
Onconova Therapeutics to Provide Corporate Update and Announce First Quarter 2021 Financial Results on May 17, 2021
May 10, 2021 08:00 ET | Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 10, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
Saniona Launches New Video Series to Highlight the Impact of Prader-Willi Syndrome and Hypothalamic Obesity on Patients and Caregivers
May 10, 2021 08:00 ET | Saniona AB
PRESS RELEASE May 10, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced its “Saniona’s Community Voices” video series, which will...
Saniona lanserar ny videoserie för att belysa hur Prader-Willis syndrom och hypotalamisk fetma drabbar patienter och anhöriga
May 10, 2021 08:00 ET | Saniona AB
PRESSMEDDELANDE 10 maj 2021 Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling fokuserad på sällsynta sjukdomar, tillkännager idag videoserien ”Saniona’s Community Voices”,...
compass_positive_tagline-01.png
COMPASS Pathways plc to announce first quarter 2021 financial results on 13 May 2021
May 06, 2021 08:00 ET | COMPASS Pathfinder Ltd.
London, UK, May 06, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...
ocugen-logo-color.png
Ocugen Presents New Preclinical OCU200 Data at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting
May 06, 2021 07:30 ET | Ocugen
OCU200, a transferrin-tumstatin fusion protein, demonstrates potential to treat DME, DR, and Wet-AMDOCU200 reduced neovascularization and damage to retina and demonstrated comparable/slightly improved...
vTv Graps Logo.png
vTv Therapeutics Announces 2021 First Quarter Financial Results and Provides Corporate Update
May 05, 2021 16:10 ET | vTv Therapeutics Inc.
Awarded Breakthrough Therapy designation for TTP399 for the treatment of type 1 diabetes Initiated two phase 1 clinical studies, mechanistic study of TTP399 and multiple ascending dose study of...
Full logo horizontal[2].png
Small Pharma Inc. to Commence Trading on the TSX Venture Exchange on May 6, 2021
May 05, 2021 08:50 ET | Small Pharma
VANCOUVER, British Columbia, May 05, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (formerly Unilock Capital Corp.) (TSXV: DMT) (the “Company” or “Small Pharma”) is pleased to announce that the common...
Dyadic Logo Current.jpg
Dyadic to Present at Upcoming Events
May 03, 2021 08:30 ET | Dyadic International, Inc.
JUPITER, Fla., May 03, 2021 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI) a global biotechnology company focused on further improving, applying and...